Fig. 4
From: Characterization of novel genetic alterations in salivary gland secretory carcinoma
The genetic alteration status between the case group with aggressive clinicopathologic features, such as tumor recurrence, lymph node, and/or advanced American Joint Committee on Cancer stage III, and the case group of indolent features showing no evidence of tumor recurrence, lymph node metastasis, or advanced American Joint Committee on Cancer stage III.
